Metropolitan Life Insurance Company (MetLife)’s Luminar Technologies LAZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,015
Closed -$30K 1157
2024
Q1
$30K Sell
1,015
-38
-4% -$1.39K ﹤0.01% 1661
2023
Q4
$53.2K Hold
1,053
﹤0.01% 1420
2023
Q3
$71.9K Buy
1,053
+55
+6% +$5.04K ﹤0.01% 1195
2023
Q2
$103K Buy
998
+76
+8% +$7.18K 0.01% 1004
2023
Q1
$89.7K Sell
922
-116
-11% -$12.2K ﹤0.01% 1047
2022
Q4
$77.1K Buy
1,038
+61
+6% +$6.64K ﹤0.01% 1212
2022
Q3
$107K Hold
977
0.01% 977
2022
Q2
$86.9K Buy
+977
New +$156K ﹤0.01% 1137

Other funds holding LAZR

Metropolitan Life Insurance Company (MetLife)'s LAZR Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Luminar Technologies (LAZR) in Q2 2024, closing a stake of 1,015 shares — an estimated $30K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in LAZR in Q2 2022 and held it in 8 quarters. The position peaked at $107K in Q3 2022. 253 funds tracked by Wall St. Rank hold LAZR as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Luminar Technologies position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,015 Luminar Technologies shares in Q2 2024, an estimated $30K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Luminar Technologies in Q2 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Luminar Technologies position peaked at $107K in Q3 2022.
  • 253 funds tracked by Wall St. Rank held Luminar Technologies as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.